Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Amgen Inc (AMGN)

Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 175,598,656
  • Shares Outstanding, K 538,481
  • Annual Sales, $ 33,424 M
  • Annual Income, $ 4,090 M
  • EBIT $ 8,671 M
  • EBITDA $ 14,263 M
  • 60-Month Beta 0.45
  • Price/Sales 4.91
  • Price/Cash Flow 10.87
  • Price/Book 18.48

Options Overview Details

View History
  • Implied Volatility 31.61% (+2.13%)
  • Historical Volatility 26.44%
  • IV Percentile 83%
  • IV Rank 40.25%
  • IV High 50.37% on 04/08/25
  • IV Low 18.97% on 02/20/25
  • Expected Move (DTE 6) 11.31 (3.47%)
  • Put/Call Vol Ratio 0.96
  • Today's Volume 14,972
  • Volume Avg (30-Day) 8,214
  • Put/Call OI Ratio 0.78
  • Today's Open Interest 151,536
  • Open Int (30-Day) 139,769
  • Expected Range 314.80 to 337.41

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 33 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 4.74
  • Number of Estimates 11
  • High Estimate 5.52
  • Low Estimate 4.49
  • Prior Year 5.31
  • Growth Rate Est. (year over year) -10.73%

Price Performance

See More
Period Period Low Period High Performance
1-Month
312.39 +4.39%
on 12/11/25
343.05 -4.94%
on 01/07/26
+12.25 (+3.90%)
since 12/09/25
3-Month
288.00 +13.23%
on 10/31/25
346.38 -5.85%
on 12/03/25
+30.67 (+10.38%)
since 10/09/25
52-Week
260.55 +25.16%
on 01/10/25
346.38 -5.85%
on 12/03/25
+61.89 (+23.42%)
since 01/08/25

Most Recent Stories

More News
Stocks Settle Mostly Lower as Early Rally Fades

The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed down -0.34%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.94%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.06%. March E-mini...

MSTR : 157.33 (-5.77%)
B : 47.81 (+0.78%)
HL : 22.45 (+6.85%)
CDE : 20.40 (+3.98%)
JPM : 329.19 (-0.18%)
TXN : 190.31 (+0.99%)
$IUXX : 25,766.26 (+1.02%)
AMGN : 326.10 (-1.21%)
ZNH26 : 112-070s (-0.03%)
ESH26 : 7,005.00s (+0.62%)
GLUE : 24.28 (-4.07%)
STX : 304.01 (+6.87%)
AMGEN TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

THOUSAND OAKS, Calif. , Jan. 7, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2026 J.P. Morgan Healthcare Conference at 3:45 p.m. PT on Monday, January 12, 2026. Robert A. Bradway,...

AMGN : 326.10 (-1.21%)
Worried About a K-Shaped Economy? Buy This Top Dividend ETF for 2026.

SCHD looks well-positioned to outperform significantly if the economy turns south in 2026.

LMT : 542.92 (+4.72%)
KO : 70.51 (+1.64%)
SCHD : 28.55 (+0.46%)
PEP : 139.91 (+0.39%)
ABBV : 220.08 (-1.81%)
AMGN : 326.10 (-1.21%)
PFE : 25.48 (+0.75%)
BMY : 55.86 (-0.07%)
Stocks Hover Near Record Highs on Mixed US Economic News

The S&P 500 Index ($SPX ) (SPY ) today is up +0.10%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.34%. March E-mini S&P futures (ESH26...

MSTR : 157.33 (-5.77%)
AMAT : 301.18 (+6.94%)
B : 47.81 (+0.78%)
HL : 22.45 (+6.85%)
CDE : 20.40 (+3.98%)
JPM : 329.19 (-0.18%)
TXN : 190.31 (+0.99%)
$IUXX : 25,766.26 (+1.02%)
AMGN : 326.10 (-1.21%)
ZNH26 : 112-070s (-0.03%)
ESH26 : 7,005.00s (+0.62%)
GLUE : 24.28 (-4.07%)
Stocks Supported by Lower Bond Yields

The S&P 500 Index ($SPX ) (SPY ) today is up +0.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.10%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.18%. March E-mini S&P futures (ESH26...

MSTR : 157.33 (-5.77%)
AMAT : 301.18 (+6.94%)
B : 47.81 (+0.78%)
HL : 22.45 (+6.85%)
CDE : 20.40 (+3.98%)
ADI : 300.93 (+0.59%)
JPM : 329.19 (-0.18%)
MBLY : 11.55 (+2.76%)
TXN : 190.31 (+0.99%)
$IUXX : 25,766.26 (+1.02%)
AMGN : 326.10 (-1.21%)
ZNH26 : 112-070s (-0.03%)
What to Expect From Amgen's Q4 2025 Earnings Report

Amgen will release its fourth-quarter earnings soon, and analysts anticipate a low double-digit profit dip.

XLV : 157.31 (-0.51%)
$SPX : 6,966.28 (+0.65%)
AMGN : 326.10 (-1.21%)
Stocks Finish Higher on Strength in Chip Makers and Energy Producers

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.77%. March E-mini S&P...

MSTR : 157.33 (-5.77%)
MPC : 176.17 (-0.51%)
HL : 22.45 (+6.85%)
CDE : 20.40 (+3.98%)
ADI : 300.93 (+0.59%)
GLXY : 24.94 (-2.20%)
JNJ : 204.39 (-0.66%)
SLB : 45.20 (+1.73%)
QXO : 25.00 (+1.42%)
AMGN : 326.10 (-1.21%)
COIN : 240.78 (-1.96%)
PNR : 103.06 (unch)
1 S&P 500 Stock with Exciting Potential and 2 We Question

1 S&P 500 Stock with Exciting Potential and 2 We Question

TECH : 65.70 (+1.73%)
IFF : 69.10 (+0.76%)
AMGN : 326.10 (-1.21%)
1 Safe-and-Steady Stock to Keep an Eye On and 2 We Question

1 Safe-and-Steady Stock to Keep an Eye On and 2 We Question

PB : 72.51 (+0.78%)
CSV : 44.23 (+2.76%)
AMGN : 326.10 (-1.21%)
Amgen (AMGN): Buy, Sell, or Hold Post Q3 Earnings?

Amgen (AMGN): Buy, Sell, or Hold Post Q3 Earnings?

AMGN : 326.10 (-1.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two...

See More

Key Turning Points

3rd Resistance Point 339.01
2nd Resistance Point 335.54
1st Resistance Point 330.82
Last Price 326.10
1st Support Level 322.64
2nd Support Level 319.17
3rd Support Level 314.45

See More

52-Week High 346.38
Last Price 326.10
Fibonacci 61.8% 313.59
Fibonacci 50% 303.46
Fibonacci 38.2% 293.34
52-Week Low 260.55

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar